| Code | 4040E | ||||||||||
| MA number | 16/0182/23-S | ||||||||||
| Product Form: | tbl flm 56 (4x14)x60 mg (blis.PVC/PVDC/Al-kalendár.-perfor.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Gedeon Richter Plc., Hungary | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| PIL: |
PIL_KOGAVANT 60 mg filmom obalené tablety_07.2024.pdf
|
| SPC: |
SPC_KOGAVANT 60 mg filmom obalené tablety_10.2025.pdf
|
| Safety feature | Yes |
| Data update: | 03.07.2025 |
